Callan Capital, LLC - EFFECTOR THERAPEUTICS INC ownership

EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V108. A total of 32 filers reported holding EFFECTOR THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Callan Capital, LLC ownership history of EFFECTOR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,998
-27.7%
20,0000.0%0.00%
-50.0%
Q2 2023$16,604
+135.4%
20,0000.0%0.00%
+100.0%
Q1 2023$7,054
-17.5%
20,0000.0%0.00%0.0%
Q4 2022$8,552
-22.3%
20,0000.0%0.00%
-50.0%
Q3 2022$11,000
-60.7%
20,0000.0%0.00%
-50.0%
Q2 2022$28,00020,0000.00%
Other shareholders
EFFECTOR THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,822,114$3,889,0001.78%
Abingworth LLP 4,822,114$2,730,0000.93%
OUP Management Co., LLC 1,025,697$587,0000.91%
Column Group LLC 4,309,329$2,465,0000.55%
Evolution Capital Management LLC 527,885$302,0000.44%
SECTORAL ASSET MANAGEMENT INC 2,382,644$1,363,0000.27%
Parallel Advisors, LLC 1,693,559$969,0000.04%
RESOLUTE FINANCIAL, LLC 31,000$18,0000.02%
Oasis Management Co Ltd. 100,000$57,0000.01%
Wescott Financial Advisory Group, LLC 55,556$32,0000.01%
View complete list of EFFECTOR THERAPEUTICS INC shareholders